Seller record · Telehealth service

HelloWellness

Fails 3 of 8 criteria. S2, prescription gating: Each product page says no intake form is required before paying and that the intake is completed after checkout, and it charges the plan on the day of purchase. The home page gives the same order: purchase the plan, then complete the intake, with a refund if the provider does not approve. 2 more criteria also fail; see the table below.

At a glance

HelloWellnessTelehealth service

5/8criteria passed
Price
Semaglutide $399 per 3-month plan against an original price of $599, tirzepatide $499 against $749, renewing every 11 weeks
Sells
compounded semaglutide, compounded tirzepatide, compounded NAD+, and 6 more
FDA letters
None on file
Visit HelloWellnessSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Houston-based telehealth platform aimed at men, selling compounded semaglutide, tirzepatide, NAD+, sermorelin, MICC and glutathione on 3-month plans and in bundles, with care from an outside telehealth practice. Its product pages say the plan is paid before the intake form, and no pharmacy is named.

Operating entity HelloWellness, LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSHelloWellness' website; HelloWellness' telehealth consent
S2Prescription gatingFAILHelloWellness' compounded semaglutide product page; HelloWellness' website; HelloWellness' refund policy
S3Pharmacy identificationFAILHelloWellness' website; HelloWellness' about page; HelloWellness' refund policy
S4Compounding disclosurePASSHelloWellness' compounded semaglutide product page; HelloWellness' compounded tirzepatide product page; HelloWellness' website
S5Analytical documentationFAILHelloWellness' compounded semaglutide product page; HelloWellness' FAQ; HelloWellness' terms and conditions
S6Business addressPASSHelloWellness' privacy notice; HelloWellness' terms and conditions
S7Price disclosurePASSHelloWellness' compounded semaglutide product page; HelloWellness' compounded tirzepatide product page; HelloWellness' website; HelloWellness' FAQ
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA healthcare provider reviews each intake to decide whether the plan is right, and the telehealth consent says care is provided by Telegra MD, LLC, whose professionals prescribe only on their own judgment with no guarantee of a prescription.Source: HelloWellness' website; HelloWellness' telehealth consent.
S2FAILEach product page says no intake form is required before paying and that the intake is completed after checkout, and it charges the plan on the day of purchase. The home page gives the same order: purchase the plan, then complete the intake, with a refund if the provider does not approve.Source: HelloWellness' compounded semaglutide product page; HelloWellness' website; HelloWellness' refund policy.
S3FAILNo filling pharmacy is named. The home and about pages refer to a USA-based 503A pharmacy, and the refund policy says the dispensing pharmacy's contact details appear on the prescription label.Source: HelloWellness' website; HelloWellness' about page; HelloWellness' refund policy.
S4PASSThe products are named as compounded, and the footer of every page, including each product page, states that compounded drug products are not FDA-approved and are not generic versions of any FDA-approved product.Source: HelloWellness' compounded semaglutide product page; HelloWellness' compounded tirzepatide product page; HelloWellness' website.
S5FAILNo certificate of analysis or lot document is published on the product pages, the answers page, the terms or the refund policy.Source: HelloWellness' compounded semaglutide product page; HelloWellness' FAQ; HelloWellness' terms and conditions.
S6PASSHelloWellness, LLC, with a business address at 415 Westheimer Rd. #103, Houston, TX 77006 printed in the privacy notice. The terms name Texas law.Source: HelloWellness' privacy notice; HelloWellness' terms and conditions.
S7PASSEach product page prints a 3-month plan price beside a higher original price, charged on the day of purchase and renewing at the same price every 11 weeks: compounded semaglutide at $399 against an original price of $599, compounded tirzepatide at $499 against $749, NAD+ at $239 against $372, sermorelin at $349 against $599, MICC at $249 against $399 and glutathione at $239 against $399. The home page shows the plans as monthly figures, semaglutide at $133 against $198 and tirzepatide at $166 against $247, and its NAD+ and sermorelin figures of $79 and $116 differ from the $83 and $99 on the answers page. Bundles start at $183 a month, renewing at $549 every 11 weeks.Source: HelloWellness' compounded semaglutide product page; HelloWellness' compounded tirzepatide product page; HelloWellness' website; HelloWellness' FAQ.
S8PASSNo FDA warning letter names HelloWellness or HelloWellness, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, compounded NAD+, compounded sermorelin, MICC, glutathione, GLP-1 and NAD+ bundle, sermorelin and NAD+ bundle, GLP-1, sermorelin and NAD+ bundle.

Visit HelloWellness

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.